Happy to present our exciting clinical data on muscle strength 🏋️. Looking forward to discuss #scientific and #clinical partnerships and investment opportunities! #together #sarcopenia #aging #LSX LSX Leaders

Taking the stage at the Bio CEO & Investor #Conference in New York! We engaged in fruitful discussions, forged new partnerships, and pitched our vision for the future of #healthyaging as pioneers in #clinicalstage #longevity #biotech .

Breakthrough functional outcome from our Phase 1b #clinicaltrial of RJx-01 in #sarcopenia reveal:
💪 Improved muscle strength
🏃 Improved muscle function
🥵 Improved fatigue resistance
Full press release: ow.ly/CEob50QG03C
#aging #biotech #clinicaltrial s #healthyaging

Proud sponsor of #ICFSR24 !

#sarcopenia #clinicaltrials

👋 Welcome Gabriel, our new #datascientist ! With his expertise, we’re set to take CombinAge, our #insilico #drugdiscovery platform, to new heights, connecting the dots between #drugs and #aging . 💊💡
Find out more about him on our team page: ow.ly/RlHC50Q7N2w #biotech

Proud to be part of the Belgian #EconomicMission to Australia. It was a true privilege to showcase our success story in #sarcopenia and #healthyaging and meet HRH Princess Astrid, alongside our distinguished guest Prof. Peter Ebeling, Monash Health AIMSS. #BEmissionAUS

👋 Join us in welcoming Sandra to our team as Junior Research Associate! Sandra brings a wealth of knowledge and enthusiasm, making her a fantastic addition to our lab family. We’re thrilled to have her on board as we dive deeper into our #agingresearch in #Celegans . 💊🔬

From Rejuvenate Biomed, Dr Silke Hüttner shares her insights from industry and how we can best collaborate on drug development. #ISTRC2023

📢 Thrilled to announce positive data from our #Phase1b #clinicaltrial with RJx-01 in #sarcopenia ! We confirmed safety, tolerability and #pharmacokinetics with the proprietary formulation. A true milestone in our mission to redefine #aging .

#pressrelease : rejuvenatebiomed.com/en/news/positi…

🎉 It's our 6th #anniversary , and what an incredible ride it has been! From #insilico discovery to #clinicalstage , developing our #drugdiscovery platforms and a robust #pipeline , thank you all for being a part of our story. Together we are shaping the future of healthy #aging ! 🙏

🔬👩‍🔬👨‍🔬 Leaning on a strong team in our #lab , moving #aging #research forward! Together, we're on a mission to unlock the secrets of aging and pave the way for a healthier future.💪

📺Tune in to our @TVL feature, where our CEO shared our exciting journey at the #HealthCampus . Get an exclusive glimpse of our #lab at @Bioville and our dedicated colleagues delving into our cutting-edge #Celegans #research . 🔬
▶ tvl.be/programmas/hea…

Launching our #SeriesC #fundraising 🚀 Catch us on stage at #LSXWorldCongressUSA , where we'll unveil our #platformtechnologies and pipeline in age-related diseases. Ready to connect with #investors and #pharma leaders: ow.ly/HTaF50PGj3S
LSX Leaders #healthyaging #sarcopenia

Andrea Maier Centre for Healthy Longevity Columbia Psychiatry Charité - Universitätsmedizin Berlin Dr. Evi Mercken, the CSO of Rejuvenate Biomed talks about tackling sarcopenia with a combined treatment of galantamine and metformin #ardd #ardd 2023

Delighted to speak at #ARDD2023 . Our CSO will present preclinical #sarcopenia data on RJx-01, that significantly increases muscle mass, strength, and physical performance in mouse models, and is being evaluated in a Phase 1b #clinicaltrial . rejuvenatebiomed.com ARDD Meeting

Congrats Caterina Tezze, PhD, Sandri_Lab and other authors for this excellent #publication in JCI insight, a cherry on top of a wonderful collaboration!
#healthyaging #sarcopenia #aging rejuvenatebiomed.com/en/news/public…

Excited to publish animal model data on our first #clinical #drug candidate, RJx-01, showing significant benefits in treating #sarcopenia , the age-related loss of muscle mass and strength. Read our #paper : insight.jci.org/articles/view/… and full #pressrelease : ow.ly/woXR50PvuLI

Thrilled to announce the newest addition to our team! Join us in welcoming Frederic Godderis as our fractional Chief Strategy Officer. For more information, please visit: ow.ly/u9kY50ORu4q

#CSO #strategy #healthyaging #biotech #drugdevelopment #companygrowth

Thrilled to #showcase our company at #BIO2023 in Boston. Our CEO and CFO are excited to meet like-minded #pharma companies, #investors and individuals to discuss opportunities in our #SeriesC #fundraising this year. Find us in the #partnering system: ow.ly/E2Zi50Owxqg

Introducing CombinAge: our proprietary platform for pathway-driven drug development to impact the aging process ▶ Watch our CEO Ann Belien, PhD pitch at the LSX World Congress @LSXleaders: lnkd.in/eAK52Pmf
#drugdevelopment #aging #biotech #fundraising #LSXworld #platform